P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells.
about
Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt.Corneal wound healing is compromised by immunoproteasome deficiency.Role of p38 MAP Kinase Signal Transduction in Solid TumorsDisruption of prostate epithelial differentiation pathways and prostate cancer development.MAP Kinases and Prostate Cancer.Ifit1 Protects Against Lipopolysaccharide and D-galactosamine-Induced Fatal Hepatitis by Inhibiting Activation of the JNK Pathway.Cytokine effects on cell viability and death of prostate carcinoma cells.Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling.Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosis.Furanodienone induces cell cycle arrest and apoptosis by suppressing EGFR/HER2 signaling in HER2-overexpressing human breast cancer cells.Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF-7 cells.H(2)O (2)-induced secretion of tumor necrosis factor-α evokes apoptosis of cardiac myocytes through reactive oxygen species-dependent activation of p38 MAPK.Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
P2860
Q33294129-2C4E9EAD-4561-4498-930F-3090713D0DD0Q34415685-3FDBF012-45B6-422B-AF00-76928E01D356Q34568307-50C92AC2-57E8-4761-9AC1-22045CEF789EQ37392558-2259456D-253A-4248-9512-D2B7201A2848Q38160495-0FBA4E07-38FC-4E74-BF84-94AA015A97DEQ38791344-0A9A5FF9-7A21-4BFF-9539-8F36C4523CA3Q38828479-3912CC9F-BB32-4E60-AA3C-DEF621250BAEQ38979197-4D0C5B67-0941-47AA-A927-EFA187A67838Q39089770-378CB831-FB4E-4591-AFD8-69BF0C5A1302Q39259464-EC62B923-52E0-4534-847B-DEA86980F29AQ39290799-2EF640AC-35B5-4D39-A5F6-BE9F66FE8EC7Q39565133-5290F2ED-9201-41DE-B165-7BC8A9D8EDEDQ39633171-8EE3A7F6-046B-4F41-B490-7C7346F94DC7Q40511032-AC81C502-D803-416F-B52E-95C91AA21095Q42078200-F9DF50BC-384D-4773-8031-34A3F9ACFEB0
P2860
P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells.
@en
type
label
P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells.
@en
prefLabel
P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells.
@en
P2093
P1433
P1476
P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells
@en
P2093
P2888
P304
P356
10.1007/S10495-006-0086-9
P577
2006-11-01T00:00:00Z